←RXRX · $3.74

Recursion Pharmaceuticals

RXRX · Market closed

$3.74

-3.62% today·exchange $3.74

exchange $3.74

Sep 21$3.63 – $4.14Sep 25

1D 1W 1M 1Y

News · Recursion Pharmaceuticals

Analysts move HubSpot 29 places higher in power ranking
TheStreet · 1d ago
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
Zacks · 2d ago
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
TechCrunch · 3d ago
Recursion Pharmaceuticals (RXRX) Stock Moves 2.02%: What You Should Know
Zacks · 3d ago
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test
Insider Monkey · 3d ago
Tempus AI, Recursion Extend Data License, Amend Fee Structure
MT Newswires · 5d ago

Headlines from Yahoo Finance. Not investment advice.

About

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Industry: Healthcare
CEO: —